-
NMPA Issued the Announcement on Cancellation of 68 Certification Items (Third Batch)
2019-11-29
NMPA decided to cancel 68 certification items (attachment, omitted) and issued an Announcement on November 29, 2019.
-
NMPA Issued the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines
2019-12-10
NMPA has organized the formulation of the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines, which has been released on December 10, 2019.
-
NMPA Issued the Guidelines for Adverse Event Classification Standards for Clinical Trials of Preventive Vaccines
2019-12-31
NMPA has organized the drafting of and released on December 31, 2019 the Guidelines for Adverse Event Classification Standards for Clinical Trials of Preventive Vaccines.
-
NMPA Issued the Announcement on the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim)
2020-01-07
NMPA has organized the formulation of the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim).
-
NMPA Issued the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim)
2019-12-20
NMPA has organized the formulation of the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim), which was released on December 20, 2019.
